Which hedge funds own CTKB? CYTEK BIOSCIENCES INC, Q2 2026 13F holders
HealthcareMedical DevicesFollow
31 tracked hedge funds disclosed a position in CTKB (CYTEK BIOSCIENCES INC) in their Q2 2026 13F filings, worth $134.3m in total. The largest holder by portfolio weight is Topline Capital Management, LLC at 7.2% of its book. 15 opened a new position this quarter: EntryPoint Capital, LLC, Jain Global LLC, Y-Intercept (Hong Kong) Ltd, Catalyst Funds Management Pty Ltd.
31
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
15
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
0
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$11.1m
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$0
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$134m
Combined value
Sum of the holders' reported positions in the security.
2.5%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.